These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 37367595)

  • 21. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucormycosis.
    Reid G; Lynch JP; Fishbein MC; Clark NM
    Semin Respir Crit Care Med; 2020 Feb; 41(1):99-114. PubMed ID: 32000287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare-associated outbreaks due to Mucorales and other uncommon fungi.
    Davoudi S; Graviss LS; Kontoyiannis DP
    Eur J Clin Invest; 2015 Jul; 45(7):767-73. PubMed ID: 25989947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron Assimilation during Emerging Infections Caused by Opportunistic Fungi with emphasis on Mucorales and the Development of Antifungal Resistance.
    Stanford FA; Voigt K
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33143139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Mucormycosis by Fluorescence In Situ Hybridization Targeting Ribosomal RNA in Tissue Samples.
    Dalimot JJ; Smith IMC; Gerkrath J; Hartmann S; Cornely OA; Lee SC; Heitman J; Rickerts V
    J Fungi (Basel); 2022 Mar; 8(3):. PubMed ID: 35330291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India - a multi-centre study.
    Biswal M; Gupta P; Kanaujia R; Kaur K; Kaur H; Vyas A; Hallur V; Behera B; Padaki P; Savio J; Nagaraj S; Chunchanur SK; Shwetha JV; Ambica R; Nagdeo N; Khuraijam R; Priyolakshmi N; Patel K; Thamke D; Dash L; Jadhav D; Bharmal R; Bhattacharya S; Rudramurthy SM; Chakrabarti A
    J Hosp Infect; 2022 Apr; 122():173-179. PubMed ID: 35124141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mucormycosis: Current and future management perspective].
    Martín Gómez MT; Salavert Lletí M
    Rev Iberoam Micol; 2021; 38(2):91-100. PubMed ID: 34144835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucormycosis in immunochallenged patients.
    Pak J; Tucci VT; Vincent AL; Sandin RL; Greene JN
    J Emerg Trauma Shock; 2008 Jul; 1(2):106-13. PubMed ID: 19561989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of 30 cases of mucormycosis at a university hospital in Iran.
    Samarei R; Gharebaghi N; Zayer S
    Mycoses; 2017 Jul; 60(7):426-432. PubMed ID: 28321926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The TLR-NF-kB axis contributes to the monocytic inflammatory response against a virulent strain of
    Montaño DE; Hartung S; Wich M; Ali R; Jungnickel B; von Lilienfeld-Toal M; Voigt K
    Front Immunol; 2022; 13():882921. PubMed ID: 36311802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and microbiological features and outcomes of mucormycosis in critically ill patients.
    Rothe K; Braitsch K; Okrojek R; Heim M; Rasch S; Verbeek M; Schmid RM; Busch DH; Lahmer T
    Int J Infect Dis; 2021 Aug; 109():142-147. PubMed ID: 34229089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal resistance in mucorales.
    Dannaoui E
    Int J Antimicrob Agents; 2017 Nov; 50(5):617-621. PubMed ID: 28802855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antifungal combinations in Mucorales: A microbiological perspective.
    Schwarz P; Cornely OA; Dannaoui E
    Mycoses; 2019 Sep; 62(9):746-760. PubMed ID: 30830980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fungal necrotizing fasciitis, an emerging infectious disease caused by Apophysomyces (Mucorales).
    Chander J; Stchigel AM; Alastruey-Izquierdo A; Jayant M; Bala K; Rani H; Handa U; Punia RS; Dalal U; Attri AK; Monzon A; Cano-Lira JF; Guarro J
    Rev Iberoam Micol; 2015; 32(2):93-8. PubMed ID: 25576377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents.
    Chitasombat MN; Kontoyiannis DP
    Curr Opin Infect Dis; 2016 Aug; 29(4):340-5. PubMed ID: 27191199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and clinical manifestations of mucormycosis.
    Petrikkos G; Skiada A; Lortholary O; Roilides E; Walsh TJ; Kontoyiannis DP
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S23-34. PubMed ID: 22247442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing Epidemiology of Mucoralean Fungi: Chronic Cutaneous Infection Caused by Mucor irregularis.
    Chander J; Kaur M; Bhalla M; Punia RS; Singla N; Bhola K; Alastruey-Izquierdo A; Stchigel AM; Guarro J
    Mycopathologia; 2015 Oct; 180(3-4):181-6. PubMed ID: 26170185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proposed Treatment Algorithm for Invasive Fungal Infections in Trauma Patients.
    Nebeluk N; Bruno LN; Duke M; Craig R; Love G; Hunt JP; Marr A; Schoen J; Stuke L; Greiffenstein P; Smith AA
    Surg Infect (Larchmt); 2022 Aug; 23(6):550-557. PubMed ID: 35675674
    [No Abstract]   [Full Text] [Related]  

  • 39. Our 2014 approach to mucormycosis.
    Tacke D; Koehler P; Markiefka B; Cornely OA
    Mycoses; 2014 Sep; 57(9):519-24. PubMed ID: 24829170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis - A comprehensive review.
    Singh A; Ahmad N; Varadarajan A; Vikram N; Singh TP; Sharma S; Sharma P
    Int J Biol Macromol; 2021 Sep; 187():988-998. PubMed ID: 34324905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.